Yamaguchi H, Nakazato M, Miyazato M, Toshimori H, Oki S, Shimizu K, Suiko M, Kangawa K, Matsukura S
Third Department of Internal Medicine, Miyazaki Medical College, Kiyotake, Japan.
Hum Genet. 1998 Jun;102(6):635-9. doi: 10.1007/s004390050754.
We report studies of two unrelated Japanese patients with 17alpha-hydroxylase deficiency caused by mutations of the 17alpha-hydroxylase (CYP17) gene. We amplified all eight exons of the CYP17 gene, including the exon-intron boundaries, by the polymerase chain reaction and determined their nucleotide sequences. Patient 1 had novel, compound heterozygous mutations of the CYP17 gene. One mutant allele had a guanine to thymine transversion at position +5 in the splice donor site of intron 2. This splice-site mutation caused exon 2 skipping, as shown by in vitro minigene expression analysis of an allelic construct, resulting in a frameshift and introducing a premature stop codon (TAG) 60 bp downstream from the exon 1-3 boundary. The other allele had a missense mutation of His (CAC) to Leu (CTC) at codon 373 in exon 6. These two mutations abolished the 17alpha-hydroxylase and 17,20-lyase activities. Restriction fragment length polymorphism (RFLP) analysis with a mismatch oligonucleotide showed that the patient's mother and brother carried the splice-site mutation, but not the missense mutation. Patient 2 was homozygous for a novel 1-bp deletion (cytosine) at codon 131 in exon 2. This 1-bp deletion produces a frameshift in translation and introduces a premature stop codon (TAG) proximal to the highly conserved heme iron-binding cysteine at codon 442 in microsomal cytochrome P450 steroid 17alpha-hydroxylase (P450c17). RFLP analysis showed that the mother was heterozygous for the mutation.
我们报告了对两名无血缘关系的日本患者的研究,他们因17α-羟化酶(CYP17)基因突变而患有17α-羟化酶缺乏症。我们通过聚合酶链反应扩增了CYP17基因的所有八个外显子,包括外显子-内含子边界,并确定了它们的核苷酸序列。患者1具有CYP17基因新的复合杂合突变。一个突变等位基因在第2内含子剪接供体位点的+5位置发生了鸟嘌呤到胸腺嘧啶的颠换。如等位基因构建体的体外小基因表达分析所示,这种剪接位点突变导致外显子2跳跃,从而导致移码,并在外显子1-3边界下游60 bp处引入了一个提前终止密码子(TAG)。另一个等位基因在第6外显子的第373密码子处发生了从组氨酸(CAC)到亮氨酸(CTC)的错义突变。这两个突变消除了17α-羟化酶和17,20-裂解酶活性。用错配寡核苷酸进行的限制性片段长度多态性(RFLP)分析表明,患者的母亲和兄弟携带剪接位点突变,但不携带错义突变。患者2在第2外显子的第131密码子处存在一个新的1 bp缺失(胞嘧啶)纯合突变。这种1 bp缺失在翻译中产生移码,并在微粒体细胞色素P450类固醇17α-羟化酶(P450c17)中第442密码子高度保守的血红素铁结合半胱氨酸附近引入了一个提前终止密码子(TAG)。RFLP分析表明,母亲为该突变的杂合子。